RecruitingRheumatoid ArthritisInterstitial Lung Disease
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Eligible age
18–90 yrs
Accepts
All genders
Locations
4 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.
Sponsor: University of Colorado, Denver
You may qualify if…
- ✓ Multidisciplinary diagnosis of RA-ILD based on the 2010 American College of Rheumatology criteria
- ✓ 18 years of age or older
You may not qualify if…
- ✕ Prior medication treatment specifically for RA-ILD
- ✕ Inability to give informed consent
- ✕ Pregnant women
Where it's recruiting
Source: ClinicalTrials.gov · NCT06397677 · last updated 2024-05-03